Harrow, Inc. Gain (Loss) Related to Litigation Settlement
Harrow, Inc. (HROW) reported Gain (Loss) Related to Litigation Settlement of $551.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-21.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2017-03-21
- Harrow, Inc. gain (loss) related to litigation settlement for the quarter ending 2016-12-31 was $0.00.
- Harrow, Inc. gain (loss) related to litigation settlement for the quarter ending 2013-03-31 was $0.00.
- Harrow, Inc. gain (loss) related to litigation settlement for the quarter ending 2012-03-31 was $0.00.
- Harrow, Inc. gain (loss) related to litigation settlement for the quarter ending 2011-12-31 was $0.00.
- Harrow, Inc. gain (loss) related to litigation settlement for fiscal 2016 was $551.00K.
- Harrow, Inc. gain (loss) related to litigation settlement for fiscal 2012 was $0.00.
- Harrow, Inc. gain (loss) related to litigation settlement for fiscal 2011 was $0.00.
- Harrow, Inc. gain (loss) related to litigation settlement for fiscal 2010 was $0.00.
| Period end | Gain (Loss) Related to Litigation Settlement 1 month | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 12 month | Gain (Loss) Related to Litigation Settlement 155 month | Gain (Loss) Related to Litigation Settlement 158 month | Gain (Loss) Related to Litigation Settlement 161 month | Gain (Loss) Related to Litigation Settlement 164 month | Gain (Loss) Related to Litigation Settlement 167 month | Gain (Loss) Related to Litigation Settlement 170 month | Gain (Loss) Related to Litigation Settlement 173 month | Gain (Loss) Related to Litigation Settlement 176 month | Gain (Loss) Related to Litigation Settlement 182 month | Gain (Loss) Related to Litigation Settlement 185 month | Gain (Loss) Related to Litigation Settlement 188 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21 | $551.00K 10-K · filed 2017-03-21 | ||||||||||||||
| 2016-09-30 | $551.00K 10-Q · filed 2016-11-14 | |||||||||||||||
| 2016-08-31 | $40.00M 10-K · filed 2017-03-21 | |||||||||||||||
| 2014-03-31 | $375.00K 10-Q · filed 2014-05-15 | |||||||||||||||
| 2013-12-31 | $375.00K 10-K · filed 2014-03-28 | |||||||||||||||
| 2013-09-30 | $375.00K 10-Q · filed 2013-11-06 | |||||||||||||||
| 2013-06-30 | $375.00K 10-Q · filed 2013-08-14 | |||||||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-08 | $375.00K 10-Q · filed 2013-05-08 | ||||||||||||||
| 2012-12-31 | $0.00 10-K · filed 2013-03-18 | $375.00K 10-K · filed 2013-03-18 | ||||||||||||||
| 2012-09-30 | $375.00K 10-Q · filed 2012-11-14 | |||||||||||||||
| 2012-06-30 | $375.00K 10-Q · filed 2012-08-14 | |||||||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-08 | $0.00 derived: sum of 2 quarters · filed 2013-05-08 | $0.00 derived: sum of 3 quarters · filed 2013-05-08 | $0.00 derived: sum of 4 quarters · filed 2013-05-08 | $375.00K 10-Q · filed 2012-05-10 | |||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | $0.00 derived: sum of 3 quarters · filed 2013-03-18 | $0.00 10-K · filed 2013-03-18 | $375.00K 10-K · filed 2012-02-23 | |||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-02-23 | $0.00 derived: sum of 2 quarters · filed 2012-02-23 | $0.00 10-Q · filed 2012-02-23 | $0.00 derived: sum of 4 quarters · filed 2012-05-10 | $375.00K 10-Q · filed 2012-02-23 | |||||||||||
| 2011-06-30 | $0.00 10-Q · filed 2012-02-23 | $0.00 10-Q · filed 2012-02-23 | $0.00 derived: sum of 3 quarters · filed 2012-05-10 | $0.00 derived: sum of 4 quarters · filed 2012-05-10 | $375.00K 10-Q · filed 2012-02-23 | |||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-10 | $0.00 derived: sum of 2 quarters · filed 2012-05-10 | $0.00 derived: sum of 3 quarters · filed 2012-05-10 | $0.00 derived: sum of 4 quarters · filed 2012-05-10 | ||||||||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $0.00 derived: sum of 2 quarters · filed 2012-02-23 | $0.00 derived: sum of 3 quarters · filed 2012-02-23 | $0.00 10-K · filed 2012-02-23 | ||||||||||||
| 2010-09-30 | $0.00 10-Q · filed 2012-02-23 | $0.00 derived: sum of 2 quarters · filed 2012-02-23 | $0.00 10-Q · filed 2012-02-23 | |||||||||||||
| 2010-06-30 | $0.00 10-Q · filed 2012-02-23 | $0.00 10-Q · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |